Dry Powder Inhalation (DPI) is a leading drug delivery technology for the treatment of respiratory diseases, and increasingly for systemic drug delivery. Optimizing a DPI capsule is not an easy task; understanding the relationship between the device, formulation and capsule is key to improve drug performances.
Four industry experts will provide insight into state-of-the-art technologies for inhalation drug development:
Speakers:
See the webinar here: